Wednesday - November 6, 2024
IU Faculty-Founded Company Awarded $2 Million Grant for Anticancer Treatment
August 09, 2024
BLOOMINGTON, Indiana, Aug. 9 -- Indiana University issued the following news release:

NERx Biosciences, a pre-clinical stage biotechnology company, was awarded a $2 million grant from the National Institutes of Health's National Cancer Institute to further develop small molecule inhibitors that target the DNA Damage Response pathway for difficult-to-treat cancers, such as lung and ovarian cancer.

Cisplatin, the most prescribed cancer therapeutic, is known to cause DNA d . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products